Updated
Updated · Swarajya · Jul 10
BioCompute Moves to San Francisco With Seed Round as 85% of Indian Startups Miss Series A
Updated
Updated · Swarajya · Jul 10

BioCompute Moves to San Francisco With Seed Round as 85% of Indian Startups Miss Series A

1 articles · Updated · Swarajya · Jul 10

Summary

  • Anagha Rajesh shifted BioCompute from Bengaluru to San Francisco in mid-2026, taking its seed round with her after building a DNA-in-bacteria data-storage prototype in India.
  • 85% of India’s seed-funded startups never reach Series A, and that funding cliff is harsher for deep-tech ventures like BioCompute, whose commercial timeline is still 5 to 10 years away.
  • More than 60% of Indian venture funding still goes to consumer tech, SaaS and fintech, while deep-tech drew about $1.6 billion in both 2024 and 2025, leaving few domestic investors able to back multiple long science rounds.
  • India has begun trying to fill that gap with a Rs 1 lakh crore research and innovation fund, a deep-tech fund-of-funds and private initiatives targeting Series A and beyond, but execution remains uncertain.
  • San Francisco still offers the denser mix of synthetic-biology talent, pilot customers and credible exit paths that a pre-revenue science startup needs, making BioCompute’s move as much about ecosystem depth as capital.

Insights

With billions in new funding, can India build a deep-tech ecosystem that rivals Silicon Valley's pull on global innovators?
Is a startup's relocation a sign of home country failure, or a smart global strategy for ambitious deep-tech founders?

From Bengaluru to San Francisco: BioCompute’s $600K Leap and the Challenge of Scaling Deep-Tech in India

Overview

BioCompute, led by Anagha Rajesh, has relocated from Bengaluru to San Francisco to accelerate its mission of developing innovative chips for DNA data storage. This move is a strategic step to access San Francisco’s strong ecosystem, which supports advanced product development and faster market entry. By focusing on building its first chips, BioCompute aims to harness the transformative potential of DNA data storage, offering unmatched data density and longevity. The company is now positioned at the forefront of this revolutionary technology, aligning its efforts to deliver its initial product directly to customers and drive the future of data storage.

...